investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Single Molecule Imaging
David Rueda
0 Collaborator(s)
Funding source
Medical Research Council (MRC)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David Rueda
MRC Clinical Sciences Centre (MRC)
London, United Kingdom
Related projects
Martha L Slattery
miRNA and Colorectal Cancer: Associations with Tumor Phenotype and Survival
Colorectum
Simon A Gayther
The Contribution of Rare Alleles to Ovarian Cancer in the Population
Ovary
Pathology
Xiaodong Zhang
Structural and mechanistic studies of the breast cancer tumour suppressor BRCA2 in DNA double strand break repair
Breast
Pathology
Sylvia Richardson
Statistical Genomics and the Analysis of High Dimensional Data
Breast
Sarah J Nechuta
Modifiable Lifestyle-Related Factors and Triple Negative Breast Cancer Prognosis
Breast
Mary B Terry
Genes, Environment and Breast Cancer Risk: The 15 Year Follow-Up of the Prof-SC
Breast
Richard Peto
Large randomised trials and meta-analyses of breast cancer treatments
Breast
Victoria Harding
The role of miRNAs in regulation and signalling induced by a new oncogenic kinase, LMTK3
Breast
Susan J Ramus
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Ovary
Pathology